Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependent mitochondrial signalling pathway

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 11, 2014, Pages 2198-2212

  Song, Xiaodong ^a,b   Wang, Bingsi ^b   Lin, Shengcui ^b   Jing, Lili ^b   Mao, Cuiping ^b   Xu, Pan ^c   Lv, Changjun ^c   Liu, Wen ^a   Zuo, Ji ^a  

^a FUDAN UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c Binzhou Medical University Affiliated Hospital   (China)

Author keywords

ROS; Astaxanthin; Lung fibrosis; Mitochondrial signalling pathway; Oxidative stress

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; CYTOCHROME C; FREE RADICAL; REACTIVE OXYGEN METABOLITE; XANTHOPHYLL;

APOPTOSIS; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; FIBROSIS; HUMAN; LUNG ALVEOLUS; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; APOPTOSIS; CELL LINE; CYTOCHROMES C; EPITHELIAL CELLS; FIBROSIS; FREE RADICALS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PULMONARY ALVEOLI; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; XANTHOPHYLLS;

EID: 84911165025     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12347     Document Type: Article

References (54)

1. Ward PA, Hunninghake GW. Lung inflammation and fibrosis. Am J Respir Crit Care Med. 1998; 157: S123-9.
2. Du Bois RM. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov. 2010; 9: 129-40.
3. Cheresh P, Kim SJ, Tulasiram S, et al. Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta. 2013; 1832: 1028-40.
4. Jain M, Rivera S, Monclus EA, et al. Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling. J Biol Chem. 2013; 288: 770-7.
5. Khanduja KL, Kaushik G, Khanduja S, et al. Corticosteroids affect nitric oxide generation, total free radicals production, and nitric oxide synthase activity in monocytes of asthmatic patients. Mol Cell Biochem. 2011; 346: 31-7.
6. Turci M, Tomatis IG, Lesci N, et al. The iron-related molecular 967 toxicity mechanism of synthetic asbestos nanofibres: a model study for 968 high-aspect-ratio nanoparticles. Chemistry. 2011; 17: 350-8.
7. Kapetanaki MG, Mora AL, Rojas M. Influence of age on wound healing and fibrosis. J Pathol. 2013; 229: 310-22.
8. Yuan JP, Peng J, Yin K, et al. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res. 2011; 55: 150-65.
9. Polyakov NE, Magyar A, Kispert LD. Photochemical and optical properties of water soluble xanthophyll antioxidants: aggregation vs. complexation. J Phys Chem B. 2013; 117: 10173-82.
10. Donà G, Kožuh I, Brunati AM, et al. Effect of astaxanthin on human sperm capacitation. Mar Drugs. 2013; 11: 1909-19.
11. Song XD, Zhang JJ, Wang MR, et al. Astaxanthin induces mitochondria- mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol Pharm Bull. 2011; 34: 839-44.
12. Song XD, Wang MR, Zhang LX, et al. Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin. Toxic Mech Meth. 2012; 22: 679-86.
13. Mercke OJ, Lignell A, Pettersson A, et al. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003; 19: 299-304.
14. Chew BP, Park JS. Carotenoid action on the immune response. J Nutr. 2004; 134: 257S-61S.
15. Chang CS, Chang CL, Lai GH. Reactive oxygen species scavenging activities in a chemiluminescence model and neuroprotection in rat pheochromocytoma cells by astaxanthin, beta-carotene, and canthaxanthin. Kaohsiung. J Med Sci. 2013; 29: 412-21.
16. Lee DH, Kim CS, Lee YJ. Astaxanthin protects against MPTP/MPP -induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol. 2011; 49: 271-80.
17. Wang MR, Zhang JJ, Song XD, et al. Astaxanthin ameliorates lung fibrosis both in vivo and in vitro through preventing transdifferentiation, inhibiting proliferation and promoting apoptosis of activated cells. Food Chem Toxicol. 2013; 56: 450-8.
18. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183: 788-824.
19. Song XD, Liu WL, Xie SY, et al. All-transretinoic acid suppresses epithelial-mesenchymal transition by down-regulating the TGF-β1/Smad3 signaling pathway in bleomycin-induced pulmonary fibrosis in rats. Lab Invest. 2013; 93: 1219-31.
20. Cao GH, Zhang JJ, Wang MR, et al. Differential expression of long non-coding RNAs in bleomycin-induced lung fibrosis. Inter J Mol Med. 2013; 32: 355-64.
21. He Z, Yu S, Mei G, et al. Maternally transmitted milk containing recombinant human catalase provides protection against oxidation for mouse offspring during lactation. Free Radic Biol Med. 2008; 45: 1135-42.
22. Speranza L, Pesce M, Patruno A, et al. Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secration in U937: SHP-1 as a novel biological target. Mar Drugs. 2012; 10: 890-9.
23. Kalayarasan S, Sriram N, Soumyakrishnan S, et al. Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2. Toxicol Appl Pharmacol. 2013; 271: 184-95.
24. Yashodhar PB, Shwetha KS, Amarnath S, et al. Regulation of lung injury and fibrosis by p53-Mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol. 2013; 183: 131-43.
25. Herrero R, Tanino M, Smith LS, et al. The Fas/FasL pathway impairs alveolar fluid clearance in mouse lungs. Am J Physiol Lung Cell Mol Physiol. 2013; 305: L377-88.
26. Adamson IYR, Bowden DH. Pulmonary injury and repair. Organ culture studies of murine lung after oxygen. Arch Pathol Lab Med. 1976; 100: 640-3.
27. Haschek WM, Witschi HP. Pulmonary fibrosis: a possible mechanism. Toxicol Appl Pharmacol. 1979; 51: 475-87.
28. Kuwano K, Kunitake R, Maeyama T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2011; 280: L316-25.
29. Wang R, Ibarra-Sunga O, Pick R, et al. Abrogation of bleomycininduced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L143-51.
30. Budinger GR, Mutlu GM, Eisenbart J, et al. Proapoptotic Bid is required for pulmonary fibrosis. Proc Natl Acad Sci USA. 2006; 103: 4604-9.
31. Uhal BD, Nguyen H, Dang M, et al. Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7. Am J Physiol Lung Cell Mol Physiol. 2013; 305: L33-41.
32. Barbas-Filho JV, Ferreira MA, Sesso A, et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol. 2011; 54: 132-8.
33. Plataki M, Koutsopoulos AV, Darivianaki K, et al. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest. 2005; 127: 266-74.
34. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis. Int J Biochem Cell Biol. 2008; 40: 362-82.
35. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006; 173: 769-76.
36. Bargagli E, Olivieri C, Bennett D, et al. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med. 2009; 103: 1245-56.
37. Liu R, Chen H, Bai H, et al. Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis. Toxicol Lett. 2013; 220: 15-25.
38. Antonsson B. Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem. 2004; 256: 141-55.
39. Yang JC, Cortopassi GA. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med. 1998; 24: 624-31.
40. Umesh CS, Yadav KV, Ramana SK. Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells. Free Radic Biol Med. 2013; 65: 15-25.
41. Singh S, Vrishni S, Singh BK, et al. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res. 2010; 44: 1267-88.
42. Kode A, Rajendrasozhan S, Caito S, et al. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L478-88.
43. He X, Chen MG, Ma Q. Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem Res Toxicol. 2008; 21: 1375-83.
44. Wu KC, Zhang Y, Klaassen CD. Nrf2 protects against diquat-induced liver and lung injury. Free Radic Res. 2012; 46: 1220-9.
45. Boutten A, Goven D, Boczkowski J, et al. Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway. Expert Opin Ther rgets. 2010; 14: 329-46.
46. Cho HY, Van Houten B, Wang X, et al. Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal. 2012; 17: 1066-82.
47. Cho HY, Imani F, Miller-DeGraff L, et al. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med. 2009; 179: 138-50.
48. Cho HY, Reddy SP, Yamamoto M, et al. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 2004; 18: 1258-60.
49. Niture SK, Jaiswal AK. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival anddrug resistance. Free Radic Bio Med. 2013; 57: 119-31.
50. Niture SK, Jaiswal AK. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Bio Chem. 2012; 287: 9873-86.
51. Joo MS, Lee CG, Koo JH, et al. MiR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury. Cell Death Dis. 2013; 4: e899.
52. Aleksunes LM, Goedken MJ, Rockwell CE, et al. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J Pharmacol Exper Ther. 2010; 335: 2-12.
53. Sablina AA, Budanov AV, Ilyinskaya GV, et al. The antioxidant function of the p53 tumor suppressor. Nat Med. 2005; 11: 1306-13.
54. Tomko RJ Jr, Bansal P, Lazo JS. Airing out an antioxidant role for the tumor suppressor p53. Mol Interv. 2006; 6: 23-5.